Impacts of COVID-19 Pandemic on the Conduct of Clinical Trials
DOI:
https://doi.org//10.32628/IJSRST229383Keywords:
SAR-CoV -2 , Pandemic, COVID-19, Clinical trailsAbstract
The main objective of this study was to explore the effects of the coronavirus disease 2019 epidemic on the ongoing and upcoming all the clinical trials. The coronavirus (SARS-CoV-2) is a strain of Coronavirus that affected worldwide. The COVID-19 pandemic has Impacted all sectors of life including the conduct of clinical Trials of medicinal products globally. The COVID-19 had caused major disruptions to the all clinical trial mainly the non-COVID trails. An estimated 80% of non-COVID-19 trials were stopped or has been interrupted as a result of the COVID-19 pandemic.The effect of pandemic challenges will depend on the severity duration of each wave of the COVID 19 pandemic the duration of the trial. Therefore, in this study, we analysed the impact of COVID-19 on clinical trials, and alternative steps to continue non-COVID clinical trials.
References
- COVID-19 and Its Impact on the Future of Clinical Trial Execution October 23, 2020 Stephen Le Breton, Mary Jo Lambert, PhD, Adam Dion, Kenneth A. Getz.
- The impact of COVID-19 on clinical trials Malke Asaad, Nilofer Khan Habibullah, Charles E Butler Annals of surgery 272 (3), e222, 2020.
- Impact of the COVID-19 pandemic on clinical research Katherine R Tuttle Nature Reviews Nephrology 16 (10), 562-564, 2020
- Obstacles and Considerations Related to Clinical Trial Research During the COVID-19 Pandemic Hasan Hashem1,Mohammad Abufaraj, Abdelghani Tbakhi and Iyad Sultan.
- The COVID-19 pandemic and new clinical trial activations From the Unger Group, Division of Public Health Sciences MAY 17, 2021 • BY COCO DAVIS / FRED HUTCHINSON CANCER RESEARCH CENTER.
- COVID-19 and readjusting clinical trials Aaron van Dorn The Lancet 396 (10250), 523-524, 2020.
- The COVID-19 pandemic and new clinical trial activations Joseph M Unger, Hong Xiao Trials 22 (1), 1-5, 2021
- Impact of COVID-19 on research L Harper, N Kalfa, GMA Beckers, M Kaefer, AJ Nieuwhof-Leppink, Magdalena Fossum, KW Herbst, D Bagli,ESPU Research Committee Journal of paediatrics urology 16 (5), 715716,2020.
- Brijesh Sathian, Mohammad Asim, Indrajit Banerjee, Ana Beatriz Pizarro, Bedanta Roy, Edwin R van Teijlingen, Israel Júnior Borges do Nascimento,Hanadi Khamis Alhamad Nepal journal of epidemiology 10 (3), 878, 2020.
- Impact of COVID-19 on the clinical trial Zhimin Chen, Liran Chen, Hua fang Chen PloS one 16 (5), e0251410, 2021.
- Clinical trials of disease stages in COVID 19: complicated and often misinterpreted Jay JH Park, Eric H Decloedt, Craig R Rayner, Mark Cotton, Edward J Mills The Lancet. Global Health 8 (10), e1249, 2020.
- COVID-19 and Its Impact on the Future of Clinical Trial Execution October 23, 2020 Stephen Le Breton, Mary Jo Lamberti, PhD, Adam Dion, Kenneth A. Getz.
Downloads
Published
Issue
Section
License
Copyright (c) IJSRST
This work is licensed under a Creative Commons Attribution 4.0 International License.